{"id": "1352310602249744384", "creation": 1611250946.0, "user_id": "1323376684490514433", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "\u201cVaxart's $733 million market value (versus Novavax's $8.1 billion) means it's easier for the stock price to double or triple. Today, Vaxart trades for about $7 a share, while Novavax trades for $124\u201d #VXRT $NVAX #vaccine #COVID19 #Covid_19 \n\nhttps://t.co/lpYfzkk1VR", "first_save": 1634559108.199414, "hashtags": ["#VXRT", "#VACCINE", "#COVID19", "#COVID_19"]}